论文部分内容阅读
The talk will discuss the advantages of analyzing multiple omics data sets, enabling such data to be visualized in a biological context through the use of bioinformatics.Several examples will be provided that illustrate the acceleration of biomarker discovery & drug safety research.One example will show how the integration of transcriptomic and metabolomics data enables improved experimental design of proteomics workflows, and accelerated identification of druggable targets forming the basis for subsequent structural studies and characterization.